GSK Prevails in Second Zantac Cancer Case to Go to Trial
GSK Plc convinced an Illinois jury that the former heartburn drug Zantac was not liable for a woman’s colorectal cancer in a second trial win for the British drugmaker. It comes just over two months after jurors in Chicago also …
Source: Claims Journal